UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 169

Sortiert nach

Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment

PloS one, 2021-10, Vol.16 (10), p.e0258858-e0258858

2021

Volltextzugriff (PDF)

PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection

PLoS pathogens, 2021-05, Vol.17 (5), p.e1009594-e1009594

2021

Volltextzugriff (PDF)

HIV vaccines beyond COVID‐19: merits of trust

Journal of the International AIDS Society, 2021-05, Vol.24 (5), p.e25742-n/a

Kublin, James G

2021

Volltextzugriff (PDF)

Dual Infection with HIV and Malaria Fuels the Spread of Both Diseases in Sub-Saharan Africa

Science (American Association for the Advancement of Science), 2006-12, Vol.314 (5805), p.1603-1606

2006

Volltextzugriff (PDF)

Statistical design and analysis of controlled human malaria infection trials

Malaria journal, 2024-05, Vol.23 (1), p.133-133, Article 133

2024

Volltextzugriff (PDF)

Human gut microbiota is associated with HIV-reactive immunoglobulin at baseline and following HIV vaccination

PloS one, 2019-12, Vol.14 (12), p.e0225622-e0225622

2019

Volltextzugriff (PDF)

Reference and point-of-care testing for G6PD deficiency: Blood disorder interference, contrived specimens, and fingerstick equivalence and precision

PloS one, 2021-09, Vol.16 (9), p.e0257560-e0257560

2021

Volltextzugriff (PDF)

Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk

PLoS pathogens, 2021-03, Vol.17 (3), p.e1009363-e1009363

2021

Volltextzugriff (PDF)

Growth Rate of Plasmodium falciparum: Analysis of Parasite Growth Data From Malaria Volunteer Infection Studies

The Journal of infectious diseases, 2020-03, Vol.221 (6), p.963-972

2020

Volltextzugriff (PDF)

Adolescent BCG revaccination induces a phenotypic shift in CD4+ T cell responses to Mycobacterium tuberculosis

Nature communications, 2024-06, Vol.15 (1), p.5191-15

2024

Volltextzugriff (PDF)

Tuberculosis vaccines and prevention of infection

Microbiology and molecular biology reviews, 2014-12, Vol.78 (4), p.650-671

2014

Volltextzugriff (PDF)

Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

The New England journal of medicine, 2013-11, Vol.369 (22), p.2083-2092

2013

Volltextzugriff (PDF)

Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study

The Lancet infectious diseases, 2014-05, Vol.14 (5), p.388-396

2014

Volltextzugriff (PDF)

A Randomized Trial Evaluating the Prophylactic Activity of DSM265 Against Preerythrocytic Plasmodium falciparum Infection During Controlled Human Malarial Infection by Mosquito Bites and Direct Venous Inoculation

The Journal of infectious diseases, 2018-02, Vol.217 (5), p.693-702

2018

Volltextzugriff (PDF)

Review of Current Tuberculosis Human Infection Studies for Use in Accelerating Tuberculosis Vaccine Development: A Meeting Report

The Journal of infectious diseases, 2024-08, Vol.230 (2), p.e457-e464

2024

Volltextzugriff (PDF)

The Regulation of Nucleic Acid Vaccine Responses by the Microbiome

The Journal of immunology (1950), 2023-12, Vol.211 (11), p.1680

2023

Volltextzugriff (PDF)

A mixed methods investigation of implementation barriers and facilitators to a daily mobile phone sexual risk assessment for young women in Soweto, South Africa

PloS one, 2020-04, Vol.15 (4), p.e0231086

2020

Volltextzugriff (PDF)

Patterns and predictors of COVID-19 vaccination among young adults at 44 US sites: Secondary analysis of a randomized, controlled, open-label trial, March – December 2021

Vaccine, 2024-08, Vol.42 (23), p.126237, Article 126237

2024

Volltextzugriff (PDF)

Factors associated with reactogenicity to an investigational HIV vaccine regimen in HIV vaccine trials network 702

Vaccine, 2024-08, Vol.42 (20), p.125991-None, Article 125991

2024

Volltextzugriff (PDF)

Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery

The Journal of infectious diseases, 2013-09, Vol.208 (5), p.818-829

2013

Volltextzugriff (PDF)

Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study

PLoS medicine, 2021-12, Vol.18 (12), p.e1003868-e1003868

2021

Volltextzugriff (PDF)

A genetically engineered Plasmodium falciparum parasite vaccine provides protection from controlled human malaria infection

Science translational medicine, 2022-08, Vol.14 (659), p.eabn9709

2022

Volltextzugriff (PDF)

Rethinking detection of pre-existing and intervening Plasmodium infections in malaria clinical trials

Frontiers in immunology, 2022-09, Vol.13, p.1003452-1003452

2022

Volltextzugriff (PDF)

Safety, Pharmacokinetics, and Causal Prophylactic Efficacy of KAF156 in a Plasmodium falciparum Human Infection Study

Clinical infectious diseases, 2021-10, Vol.73 (7), p.e2407-e2414

2021

Volltextzugriff (PDF)

1 – 25 von 169

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(163)
Mit Volltextzugriff
(143)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(128)
Humans
(109)
Life Sciences & Biomedicine
(106)
Hiv
(72)
Infectious Diseases
(72)
Immunology
(66)
Female
(58)
Vaccines
(57)
Human Immunodeficiency Virus
(55)
Male
(55)
Adult
(54)
Hiv Infections - Prevention & Control
(40)
Malaria
(39)
Aids
(35)
Microbiology
(35)
Clinical Trials
(34)
Young Adult
(33)
Infections
(31)
Vaccination
(31)
Adolescent
(29)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment

PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection

HIV vaccines beyond COVID‐19: merits of trust

Dual Infection with HIV and Malaria Fuels the Spread of Both Diseases in Sub-Saharan Africa

Statistical design and analysis of controlled human malaria infection trials

Human gut microbiota is associated with HIV-reactive immunoglobulin at baseline and following HIV vaccination

Reference and point-of-care testing for G6PD deficiency: Blood disorder interference, contrived specimens, and fingerstick equivalence and precision

Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk

Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study

Growth Rate of Plasmodium falciparum: Analysis of Parasite Growth Data From Malaria Volunteer Infection Studies

Adolescent BCG revaccination induces a phenotypic shift in CD4+ T cell responses to Mycobacterium tuberculosis

Tuberculosis vaccines and prevention of infection

Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study

A Randomized Trial Evaluating the Prophylactic Activity of DSM265 Against Preerythrocytic Plasmodium falciparum Infection During Controlled Human Malarial Infection by Mosquito Bites and Direct Venous Inoculation

Review of Current Tuberculosis Human Infection Studies for Use in Accelerating Tuberculosis Vaccine Development: A Meeting Report

The Regulation of Nucleic Acid Vaccine Responses by the Microbiome

A mixed methods investigation of implementation barriers and facilitators to a daily mobile phone sexual risk assessment for young women in Soweto, South Africa

Patterns and predictors of COVID-19 vaccination among young adults at 44 US sites: Secondary analysis of a randomized, controlled, open-label trial, March – December 2021

Factors associated with reactogenicity to an investigational HIV vaccine regimen in HIV vaccine trials network 702

Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery

Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study

A genetically engineered Plasmodium falciparum parasite vaccine provides protection from controlled human malaria infection

Rethinking detection of pre-existing and intervening Plasmodium infections in malaria clinical trials

Safety, Pharmacokinetics, and Causal Prophylactic Efficacy of KAF156 in a Plasmodium falciparum Human Infection Study

Suchergebnisse filtern